drugset / Trial / NCT06133803
Lovenox With Aspirin in Thawed Blastocyst Transfer
RandomizedParallel-groupOpen-labelTreatment
Summary
This prospective randomized trial will compare outcomes in patients receiving aspirin in combination with a low-molecular weight heparin and those under this center's standard protocol receiving neither medication, in order to determine if these medications may improve success rates.
Timeline
- Start
- 2024-01-26
- Primary completion
- 2024-12-15
- Completion
- 2024-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |
| Subject | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |